917 related articles for article (PubMed ID: 32456404)
1. The vaccine journey for COVID-19: a comprehensive systematic review of current clinical trials in humans.
Checcucci E; Piramide F; Pecoraro A; Amparore D; Campi R; Fiori C; Elhage O; Kotecha P; Vyakarnam A; Serni S; Dasgupta P; Porpiglia F
Panminerva Med; 2022 Mar; 64(1):72-79. PubMed ID: 32456404
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials.
Gong W; Aspatwar A; Wang S; Parkkila S; Wu X
Expert Rev Vaccines; 2021 Jul; 20(7):857-880. PubMed ID: 34078215
[No Abstract] [Full Text] [Related]
3. Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19).
Bennet BM; Wolf J; Laureano R; Sellers RS
Toxicol Pathol; 2020 Oct; 48(7):800-809. PubMed ID: 32926660
[TBL] [Abstract][Full Text] [Related]
4. Coronavirus (SARS-CoV-2): a systematic review for potential vaccines.
Bhatta M; Nandi S; Dutta S; Saha MK
Hum Vaccin Immunother; 2022 Dec; 18(1):1865774. PubMed ID: 33545014
[TBL] [Abstract][Full Text] [Related]
5. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
6. mRNA Covid-19 vaccines in pregnancy: A systematic review.
Pratama NR; Wafa IA; Budi DS; Putra M; Wardhana MP; Wungu CDK
PLoS One; 2022; 17(2):e0261350. PubMed ID: 35108277
[TBL] [Abstract][Full Text] [Related]
7. Interpretative immune targets and contemporary position for vaccine development against SARS-CoV-2: A systematic review.
Chauhan N; Soni S; Gupta A; Aslam M; Jain U
J Med Virol; 2021 Apr; 93(4):1967-1982. PubMed ID: 33270225
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.
Lim HX; Arip M; Yahaya AAA; Jazayeri SD; Poppema S; Poh CL
Front Biosci (Landmark Ed); 2021 Nov; 26(11):1286-1304. PubMed ID: 34856768
[TBL] [Abstract][Full Text] [Related]
9. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
[TBL] [Abstract][Full Text] [Related]
10. Effects of SARS-CoV-2 Vaccines on Sperm Quality: Systematic Review.
Li G; Zhang R; Song B; Wang C; Shen Q; He X; Cao Y
JMIR Public Health Surveill; 2023 Dec; 9():e48511. PubMed ID: 37976132
[TBL] [Abstract][Full Text] [Related]
11. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 vaccine research focusses on safety, efficacy, immunoinformatics, and vaccine production and delivery: a bibliometric analysis based on VOSviewer.
Chen Y; Cheng L; Lian R; Song Z; Tian J
Biosci Trends; 2021 May; 15(2):64-73. PubMed ID: 33746182
[TBL] [Abstract][Full Text] [Related]
13. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
14. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
15. A Review of the Progress and Challenges of Developing a Vaccine for COVID-19.
Sharma O; Sultan AA; Ding H; Triggle CR
Front Immunol; 2020; 11():585354. PubMed ID: 33163000
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis.
Sharif N; Alzahrani KJ; Ahmed SN; Dey SK
Front Immunol; 2021; 12():714170. PubMed ID: 34707602
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial.
Kremsner PG; Ahuad Guerrero RA; Arana-Arri E; Aroca Martinez GJ; Bonten M; Chandler R; Corral G; De Block EJL; Ecker L; Gabor JJ; Garcia Lopez CA; Gonzales L; Granados González MA; Gorini N; Grobusch MP; Hrabar AD; Junker H; Kimura A; Lanata CF; Lehmann C; Leroux-Roels I; Mann P; Martinez-Reséndez MF; Ochoa TJ; Poy CA; Reyes Fentanes MJ; Rivera Mejia LM; Ruiz Herrera VV; Sáez-Llorens X; Schönborn-Kellenberger O; Schunk M; Sierra Garcia A; Vergara I; Verstraeten T; Vico M; Oostvogels L;
Lancet Infect Dis; 2022 Mar; 22(3):329-340. PubMed ID: 34826381
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 vaccines: concerns beyond protective efficacy and safety.
Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
[TBL] [Abstract][Full Text] [Related]
19. Favipiravir for treating patients with novel coronavirus (COVID-19): protocol for a systematic review and meta-analysis of randomised clinical trials.
Arab-Zozani M; Hassanipour S; Ghoddoosi-Nejad D
BMJ Open; 2020 Jul; 10(7):e039730. PubMed ID: 32737100
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review.
Li J; Wang Y; Liu Y; Zhang Z; Zhai Y; Dai Y; Wu Z; Nie X; Du L
Eur J Med Res; 2022 Feb; 27(1):26. PubMed ID: 35193695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]